Sarcoma  >>  Omblastys (131I-omburtamab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Omblastys (131I-omburtamab) / Y-mAbs Therap
NCT00089245 / 2020-001590-68: Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Terminated
1
177
US
Iodine I 131 MOAB 8H9
Y-mAbs Therapeutics, Memorial Sloan Kettering Cancer Center
Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
02/22
02/22

Download Options